Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America, ex rel Don Hanks v. Amgen Inc. et al
Case Number:
1:08-cv-03096
Court:
Nature of Suit:
Judge:
Firms
- Akerman LLP
- Baker & Hostetler
- Carlton Fields
- Chilivis Grubman
- Davis Wright
- Foley & Lardner
- GeyerGorey
- Gfeller Laurie
- Hennig Kramer
- Hoyer Law Group
- Kilpatrick Townsend
- King & Spalding
- K&L Gates
- Morrison Foerster
- Shutts & Bowen
- Smith Gambrell
- Stokes Wagner
- Taylor Odachowski
- Venable LLP
- Wiley Rein
Companies
- American Health Network Inc.
- Amgen Inc.
- Buffalo Medical Group Inc.
- George Washington University
- Marshfield Clinic Inc.
- Mayo Foundation for Medical Education and Research
- Nebraska Hematology Oncology
- North Memorial Health
- Palo Alto Medical Foundation
- Park Nicollet
- Regents of the University of California
- Tennessee Oncology PLLC
Government Agencies
Sectors & Industries:
-
September 18, 2024
Ex-Amgen Rep Wasn't Original Whistleblower, Judge Says
A Brooklyn federal judge tossed a former Amgen sales representative's whistleblower suit on Wednesday, saying many elements of his allegations of a kickback scheme had been disclosed in news reports and civil lawsuits prior to his filing.
-
June 03, 2020
2nd Circ. Sends FCA Discount Case For 'Original Source' Look
The Second Circuit on Wednesday revived a former Amgen Inc. sales representative's False Claims Act suit accusing numerous oncology practices of bilking Medicare, saying a lower court must examine whether the whistleblower is the original source of the allegations.